The global asthma therapeutics market is influenced by the growing focus on severe asthma, where some patients experience persistent symptoms despite optimized standard treatment. This creates demand for specialist assessment, add-on biologics, and treatment plans tailored to the underlying inflammatory profile. The asthma therapeutics market is projected to reach US$ 37.86 billion by 2031,...